HMNC Brain Health is pioneering first-in-class precision therapeutics for mental health disorders by co-developing predictive patient selection tools using biomarkers, rooted in the groundbreaking research of co-founder Prof. Florian Holsboer, former Director of the Max-Planck Institute of Psychiatry, alongside Ketabon, a non-precision approach for broader depression treatment.